Dr. Jim Cardelli

Jim Cardelli

Dr. Jim Cardelli

CTO, Oleolive


DR. JIM CARDELLI retired from LSUHSC on December 31, 2015, after thirty years of service as a faculty member to launch a company named Segue Therapeutics L.L.C. The company focused on repurposing existing drugs to target a variety of human diseases where fibrosis plays a major role especially pancreatic cancer and Idiopathic Pulmonary Fibrosis. Jim joined LSU Health Sciences Center in Shreveport in 1985 and became a Full Professor in 1993. He taught medical students and graduate students and ran a laboratory that averaged seven people for over 30 years. He trained more than 30 graduate and post graduate students during his career. He also directed the Innovative North Louisiana Experimental Therapeutics Program named INLET from 2012 to the end of 2015 and was Director of Basic and Translational Research for the Feist-Weiller Cancer Center from 1997-2014.

Oleolive LLC was launched in 2017 and is dedicated to the production and use of extra virgin olive oil (EVOO) products to increase human health. The company currently has a product on the market named SuperOli and has been awarded a $350,000 SBIR grant to continue research on oleocanthal, a compound in EVOO, as anti Alzheimer’s agent.

As of July 2020 Oleolive has 5 SBIRs in a range of indications and is one of the fastest growing companies in Louisiana.

back to top CajunCannabisConfenerce